Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1Phase 1 1

Status

Recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Melanoma 4Neoplasm Metastasis 3Lymphoma, Non-Hodgkin 2Lymphoma, Follicular 2Lymphoma, B-Cell, Marginal Zone 2Leukemia, Lymphocytic, Chronic, B-Cell 2Hodgkin Disease 2Diabetes Mellitus, Insulin-Dependent, 12 2Waldenstrom Macroglobulinemia 1Uveal Melanoma 1Triple Negative Breast Neoplasms 1Salivary Gland Neoplasms 1Rhabdomyosarcoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Osteosarcoma 1Neuroectodermal Tumors, Primitive, Peripheral 1Neuroblastoma 1Meningioma 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Immunoblastic 1Lymphoma, Large B-Cell, Diffuse 1Leukemia, Hairy Cell 1Intraocular Lymphoma 1Clear-cell metastatic renal cell carcinoma 1Carcinoma, Renal Cell 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Merkel Cell 1Carcinoma, Basal Cell 1Burkitt Lymphoma 1Breast Neoplasms 1

Interventions

pembrolizumab 2smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic 1prednylidene 1methyl 5-aminolevulinate 1gusacitinib 1deltacortene 1Specimen Handling 1Sirolimus 1Prednisone 1Photochemotherapy 1Nivolumab 1Methods 1Magnetic Resonance Spectroscopy 1MAPRE1 protein, human 1Ipilimumab 1Interleukin-2 1HhAntag691 1CTLA-4 Antigen 1Biopsy 1BF-200 ALA 1Arsenic Trioxide 1Aminolevulinic Acid 15-aminolevulinic acid hexyl ester 11-phenyl-3,3-dimethyltriazene 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Carcinoma, Basal Cell × CTLA-4 Antigen × Clear all
NCT05896839 2026-06-15

Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer

National Cancer Institute (NCI)

Phase 1/2 Recruiting
16 enrolled
Dermatologic

Carcinoma, Basal Cell, Melanoma, Carcinoma, Merkel Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡